Detalles de la búsqueda
1.
Anti-HIV Humoral Response Induced by Different Anti-Idiotype Antibody Formats: An In Silico and In Vivo Approach.
Int J Mol Sci;
25(11)2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38891926
2.
Interferon-ß-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
J Infect Dis;
222(5): 722-725, 2020 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32559285
3.
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols.
Virol J;
17(1): 103, 2020 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660499
4.
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides.
Clin Dev Immunol;
2013: 521231, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878584
5.
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?
Clin Dev Immunol;
2013: 967581, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878587
6.
New therapeutic options for HCV infection in the monoclonal antibody era.
New Microbiol;
35(4): 387-97, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109006
7.
Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
New Microbiol;
35(4): 475-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23109015
8.
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.
New Microbiol;
35(3): 289-94, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22842598
9.
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro.
Front Microbiol;
11: 1704, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32754147
10.
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).
New Microbiol;
32(4): 319-24, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20128437
11.
Editorial: Breakthroughs in immunotherapies and precision treatment against infectious diseases.
Front Cell Infect Microbiol;
12: 953312, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992164
12.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Viruses;
8(5)2016 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27164128
13.
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy.
Antiviral Res;
108: 94-103, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24909571
14.
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study.
Autoimmun Rev;
16(3): 323-325, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28161557
15.
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).
Virology;
399(1): 144-152, 2010 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20096915
Resultados
1 -
15
de 15
1
Próxima >
>>